Article
The liquid biopsy: a tool for a combined diagnostic and theranostic approach for care of a patient with late-stage lung carcinoma presenting with bilateral ocular metastases.
Expert review of anticancer therapy - 1 Dec 2017
Bouhlel Linda, Hofman Véronique, Maschi Célia, Ilié Marius, Allégra Maryline, Marquette Charles-Hugo, Audigier-Valette Clarisse, Thariat Juliette, Hofman Paul
Abstract excerpt
INTRODUCTION: Liquid biopsies (LB) are used routinely in clinical practice in two situations for late stage non-small-cell lung cancer (NSCLC) patients, (i) at the initial diagnosis when looking for activating mutations in EGFR in the absence of analyzable tissue DNA and, (ii) during tumor progression on a tyrosine kinase inhibitor treatment to look for the resistance mutation T790M in EGFR. LB is not presently...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.